Document is current
Any future updates will be listed below
-
Authors
Ishida, Masaki
Yamada, Tadaaki
Katayama, Yuki
Kawachi, Hayato
Sawada, Ryo
Nakamura, Ryota
Hirai, Soichi
Matsui, Yohei
Morimoto, Kenji
Onoi, Keisuke
Nakamura-Sasada, Aosa
Horinaka, Mano
Sakai, Toshiyuki
Sakakida, Tomoki
Doi, Toshifumi
Yasumoto, Kazuo
Goto, Yasuhiro
Furuya, Naoki
Taniguchi, Hirokazu
Ogino, Hirokazu
Takayuki, Nakano
Chihara, Yusuke
Fukuda, Koji
Taniguchi, Hiroaki
Uehara, Hisanori
Yano, Seiji
Tokuda, Shinsaku
Takayama, Koichi
-
Funding
Funding for this research was provided by:
JSPS KAKENHI (23K07607)
research grants from the Takeda Pharmaceutical Company Limited and the Takeda Science Foundation
Extramural Collaborative Research Grant of the Cancer Research Institute, Kanazawa University
- License Information
-
More Information
Article History
Received: 4 April 2025
Accepted: 16 March 2026
First Online: 2 April 2026
Competing interests
: T.Y. received commercial research grants from Ono Pharmaceutical, Janssen Pharmaceutical K.K., AstraZeneca, and Takeda Pharmaceutical Company Limited and has received speaking honoraria from Eli Lilly and Chugai Pharmaceutical Co. Ltd. Author HK received personal fees from Ono Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co. Ltd., AstraZeneca KK, Taiho Pharmaceutical Co. Ltd., Eli Lilly Japan KK, and MSD KK, outside the submitted work. T.S. received research grants from Otsuka Pharmaceutical and Oncolys BioPharma, and a patent fee from JT Pharmaceutical. Author HO received lecture honoraria from Chugai Pharmaceutical Co., Ltd., Bristol-Myers Squibb, MSD, Taiho Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., AstraZeneca, Amgen Inc., and Eisai Co., Ltd., outside the submitted work. He also reports that his institution has received institutional research funding from AstraZeneca, MSD, and Daiichi Sankyo Co., Ltd. for industry-sponsored clinical trials in thoracic oncology; these payments were made to his institution and not to him personally. Author SY obtained commercial research grants from Chugai Pharmaceutical and Boehringer-Ingelheim, and has received speaking honoraria from Chugai Pharmaceutical, Boehringer-Ingelheim, Novartis, and Pfizer. Author KT received research grants from Chugai-Roche and Ono Pharmaceutical and personal fees from AstraZeneca, Chugai-Roche, MSD-Merck, Eli Lilly, Boehringer-Ingelheim, and Daiichi-Sankyo. All other authors declare no financial or non-financial interests.
